Anesthesia is a modern hybrid-indica cultivar developed through the crossing of Skunk #1, Herijuana, and Runtz. This specific genetic composition reflects a contemporary approach to breeding, resulting in a plant that reaches maturity after a 63-day flowering period. It is categorized as a project of moderate cultivation difficulty that performs reliably in both indoor and outdoor environments, capable of producing high yields. Its genetic influence is evidenced by its significant role in further hybridization, leading to notable offspring such as Anesthesia x Runtz and the Haarlem variety.

The chemical profile of Anesthesia is defined by a complex arrangement of terpenes, led by limonene, myrcene, and caryophyllene, followed by pinene, linalool, beta-pinene, humulene, ocimene, bisabolol, nerolidol, valencene, and guaiol. This diverse array of secondary metabolites creates a nuanced aromatic and sensory profile shaped by the dominant citrus notes of limonene, the earthy undertones of myrcene, and the spicy, woody contributions of caryophyllene and pinene. The balanced influence of floral linalool and crisp beta-pinene contributes to a multifaceted experience that characterizes the strain's specific terpene hierarchy.

As a THC-dominant cultivar, Anesthesia is primarily utilized for its ability to induce states of relaxation, calm, and focus. These effects make it a tactical choice for consumers seeking support with pain, stress, and sleep management. By combining the structural characteristics of its lineage with a potent cannabinoid profile, the strain offers a functional therapeutic application. Its legacy continues in the modern cannabis market through its direct descendants, which carry forward the specific growth and effect traits observed in the original Anesthesia genotype.